Listed

Prestige Consumer Healthcare Inc.

PBHNYSECIK 1295947HealthcareFiscal year ends Mar 31

Latest reported revenue, Q1 FY2027$265.7mRevenue, Q1 FY2027, three months to 2026-06-30$265.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001295947-26-000042.Report this figureThree months to Jun 30, 2026, from the 10-Q filed Aug 6, 2026.

Latest quarter: Q1 FY2027

Three months to Jun 30, 2026, against the same quarter a year earlier.

  • Revenue$265.7mRevenue, Q1 FY2027, three months to 2026-06-30$265.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001295947-26-000042.Report this figure+6.5% on a year earlier
  • Gross margin51.3%Gross margin, Q1 FY2027, three months to 2026-06-30. gross profit / revenueGross profit: $136.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-06, accession 0001295947-26-000042.Revenue: $265.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001295947-26-000042.Report this figure−5.0 pts on a year earlier
  • Operating margin19.8%Operating margin, Q1 FY2027, three months to 2026-06-30. operating income / revenueOperating income: $52.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001295947-26-000042.Revenue: $265.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001295947-26-000042.Report this figure−9.0 pts on a year earlier
  • Net margin11.0%Net margin, Q1 FY2027, three months to 2026-06-30. net income / revenueNet income: $29.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001295947-26-000042.Revenue: $265.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001295947-26-000042.Report this figure−8.0 pts on a year earlier
  • Diluted EPS$0.61Diluted EPS, Q1 FY2027, three months to 2026-06-30$0.61 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001295947-26-000042.Report this figure−35.8% on a year earlier
  • Free cash flow$67.1mFree cash flow, Q1 FY2027, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $70.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001295947-26-000042.Capital expenditure: $3.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001295947-26-000042.Report this figure−14.2% on a year earlier

Last eight quarters

Full statements
Revenue$265.7mGross margin 51.3%
Diluted EPS$0.61, Q1 FY2027
Free cash flow$67.1m, Q1 FY2027
Prestige Consumer Healthcare Inc., key figures for the last eight quarters
Line itemUnitQ2 FY20252024-09-30Q3 FY20252024-12-31Q4 FY20252025-03-31Q1 FY20262025-06-30Q2 FY20262025-09-30Q3 FY20262025-12-31Q4 FY20262026-03-31Q1 FY20272026-06-30Shape over the periods
Revenue$m284Revenue, Q2 FY2025, three months to 2024-09-30$283.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001295947-25-000039.Report this figure290Revenue, Q3 FY2025, three months to 2024-12-31$290.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-05, accession 0001295947-26-000008.Report this figure297Revenue, Q4 FY2025, three months to 2025-03-31$296.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-05-14, accession 0001295947-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure250Revenue, Q1 FY2026, three months to 2025-06-30$249.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001295947-26-000042.Report this figure274Revenue, Q2 FY2026, three months to 2025-09-30$274.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001295947-25-000039.Report this figure283Revenue, Q3 FY2026, three months to 2025-12-31$283.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-05, accession 0001295947-26-000008.Report this figure282Revenue, Q4 FY2026, three months to 2026-03-31$281.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-05-14, accession 0001295947-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure266Revenue, Q1 FY2027, three months to 2026-06-30$265.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001295947-26-000042.Report this figure
Gross margin%55.5%Gross margin, Q2 FY2025, three months to 2024-09-30. gross profit / revenueGross profit: $157.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-06, accession 0001295947-25-000039.Revenue: $283.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001295947-25-000039.Report this figure55.5%Gross margin, Q3 FY2025, three months to 2024-12-31. gross profit / revenueGross profit: $161.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-02-05, accession 0001295947-26-000008.Revenue: $290.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-05, accession 0001295947-26-000008.Report this figure57.3%Gross margin, Q4 FY2025, three months to 2025-03-31. gross profit / revenueGross profit: $170.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-05-14, accession 0001295947-26-000016. Derived: 12-month figure less the 9-month figure.Revenue: $296.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-05-14, accession 0001295947-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure56.2%Gross margin, Q1 FY2026, three months to 2025-06-30. gross profit / revenueGross profit: $140.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-06, accession 0001295947-26-000042.Revenue: $249.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001295947-26-000042.Report this figure55.3%Gross margin, Q2 FY2026, three months to 2025-09-30. gross profit / revenueGross profit: $151.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-06, accession 0001295947-25-000039.Revenue: $274.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001295947-25-000039.Report this figure55.5%Gross margin, Q3 FY2026, three months to 2025-12-31. gross profit / revenueGross profit: $157.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-02-05, accession 0001295947-26-000008.Revenue: $283.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-05, accession 0001295947-26-000008.Report this figure51.9%Gross margin, Q4 FY2026, three months to 2026-03-31. gross profit / revenueGross profit: $146.3m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-05-14, accession 0001295947-26-000016. Derived: 12-month figure less the 9-month figure.Revenue: $281.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-05-14, accession 0001295947-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure51.3%Gross margin, Q1 FY2027, three months to 2026-06-30. gross profit / revenueGross profit: $136.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-06, accession 0001295947-26-000042.Revenue: $265.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001295947-26-000042.Report this figure
Operating margin%29.7%Operating margin, Q2 FY2025, three months to 2024-09-30. operating income / revenueOperating income: $84.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001295947-25-000039.Revenue: $283.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001295947-25-000039.Report this figure31.7%Operating margin, Q3 FY2025, three months to 2024-12-31. operating income / revenueOperating income: $92.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-05, accession 0001295947-26-000008.Revenue: $290.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-05, accession 0001295947-26-000008.Report this figure29.8%Operating margin, Q4 FY2025, three months to 2025-03-31. operating income / revenueOperating income: $88.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-05-14, accession 0001295947-26-000016. Derived: 12-month figure less the 9-month figure.Revenue: $296.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-05-14, accession 0001295947-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure28.8%Operating margin, Q1 FY2026, three months to 2025-06-30. operating income / revenueOperating income: $71.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001295947-26-000042.Revenue: $249.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001295947-26-000042.Report this figure29.1%Operating margin, Q2 FY2026, three months to 2025-09-30. operating income / revenueOperating income: $79.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001295947-25-000039.Revenue: $274.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001295947-25-000039.Report this figure29.1%Operating margin, Q3 FY2026, three months to 2025-12-31. operating income / revenueOperating income: $82.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-05, accession 0001295947-26-000008.Revenue: $283.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-05, accession 0001295947-26-000008.Report this figure26.8%Operating margin, Q4 FY2026, three months to 2026-03-31. operating income / revenueOperating income: $75.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-05-14, accession 0001295947-26-000016. Derived: 12-month figure less the 9-month figure.Revenue: $281.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-05-14, accession 0001295947-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure19.8%Operating margin, Q1 FY2027, three months to 2026-06-30. operating income / revenueOperating income: $52.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001295947-26-000042.Revenue: $265.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001295947-26-000042.Report this figure
Net margin%19.2%Net margin, Q2 FY2025, three months to 2024-09-30. net income / revenueNet income: $54.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001295947-25-000039.Revenue: $283.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001295947-25-000039.Report this figure21.0%Net margin, Q3 FY2025, three months to 2024-12-31. net income / revenueNet income: $61.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-02-05, accession 0001295947-26-000008.Revenue: $290.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-05, accession 0001295947-26-000008.Report this figure16.9%Net margin, Q4 FY2025, three months to 2025-03-31. net income / revenueNet income: $50.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-05-14, accession 0001295947-26-000016. Derived: 12-month figure less the 9-month figure.Revenue: $296.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-05-14, accession 0001295947-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure19.0%Net margin, Q1 FY2026, three months to 2025-06-30. net income / revenueNet income: $47.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001295947-26-000042.Revenue: $249.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001295947-26-000042.Report this figure15.4%Net margin, Q2 FY2026, three months to 2025-09-30. net income / revenueNet income: $42.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001295947-25-000039.Revenue: $274.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001295947-25-000039.Report this figure16.5%Net margin, Q3 FY2026, three months to 2025-12-31. net income / revenueNet income: $46.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-02-05, accession 0001295947-26-000008.Revenue: $283.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-05, accession 0001295947-26-000008.Report this figure19.1%Net margin, Q4 FY2026, three months to 2026-03-31. net income / revenueNet income: $53.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-05-14, accession 0001295947-26-000016. Derived: 12-month figure less the 9-month figure.Revenue: $281.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-05-14, accession 0001295947-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure11.0%Net margin, Q1 FY2027, three months to 2026-06-30. net income / revenueNet income: $29.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001295947-26-000042.Revenue: $265.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001295947-26-000042.Report this figure
Diluted EPS$ per share1.09Diluted EPS, Q2 FY2025, three months to 2024-09-30$1.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001295947-25-000039.Report this figure1.22Diluted EPS, Q3 FY2025, three months to 2024-12-31$1.22 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-05, accession 0001295947-26-000008.Report this figurenot reported (Diluted EPS not reported)0.95Diluted EPS, Q1 FY2026, three months to 2025-06-30$0.95 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001295947-26-000042.Report this figure0.86Diluted EPS, Q2 FY2026, three months to 2025-09-30$0.86 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001295947-25-000039.Report this figure0.97Diluted EPS, Q3 FY2026, three months to 2025-12-31$0.97 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-05, accession 0001295947-26-000008.Report this figurenot reported (Diluted EPS not reported)0.61Diluted EPS, Q1 FY2027, three months to 2026-06-30$0.61 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001295947-26-000042.Report this figure
Free cash flow$m67.8Free cash flow, Q2 FY2025, three months to 2024-09-30. operating cash flow − capital expenditureOperating cash flow: $69.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001295947-25-000039. Derived: 6-month figure less the 3-month figure.Capital expenditure: $2.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001295947-25-000039. Derived: 6-month figure less the 3-month figure.Report this figure63.5Free cash flow, Q3 FY2025, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $65.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-05, accession 0001295947-26-000008. Derived: 9-month figure less the 6-month figure.Capital expenditure: $1.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-02-05, accession 0001295947-26-000008. Derived: 9-month figure less the 6-month figure.Report this figure58.4Free cash flow, Q4 FY2025, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: $61.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-05-14, accession 0001295947-26-000016. Derived: 12-month figure less the 9-month figure.Capital expenditure: $3.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-05-14, accession 0001295947-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure78.2Free cash flow, Q1 FY2026, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: $79.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001295947-26-000042.Capital expenditure: $838.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001295947-26-000042.Report this figure55.4Free cash flow, Q2 FY2026, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: $57.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001295947-25-000039. Derived: 6-month figure less the 3-month figure.Capital expenditure: $2.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001295947-25-000039. Derived: 6-month figure less the 3-month figure.Report this figure75.3Free cash flow, Q3 FY2026, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $78.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-05, accession 0001295947-26-000008. Derived: 9-month figure less the 6-month figure.Capital expenditure: $3.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-02-05, accession 0001295947-26-000008. Derived: 9-month figure less the 6-month figure.Report this figure37.6Free cash flow, Q4 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: $42.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-05-14, accession 0001295947-26-000016. Derived: 12-month figure less the 9-month figure.Capital expenditure: $5.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-05-14, accession 0001295947-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure67.1Free cash flow, Q1 FY2027, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $70.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001295947-26-000042.Capital expenditure: $3.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001295947-26-000042.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$1.09bnGross margin 54.7%
Diluted EPS$3.91, FY2026
Free cash flow$246.4m, FY2026
Prestige Consumer Healthcare Inc., key figures for the last five fiscal years
Line itemUnitFY20222022-03-31FY20232023-03-31FY20242024-03-31FY20252025-03-31FY20262026-03-31Shape over the periods
Revenue$m1,087Revenue, FY2022, twelve months to 2022-03-31$1.09bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-05-15, accession 0001295947-24-000017.Report this figure1,128Revenue, FY2023, twelve months to 2023-03-31$1.13bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-05-09, accession 0001295947-25-000017.Report this figure1,125Revenue, FY2024, twelve months to 2024-03-31$1.13bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-05-14, accession 0001295947-26-000016.Report this figure1,138Revenue, FY2025, twelve months to 2025-03-31$1.14bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-05-14, accession 0001295947-26-000016.Report this figure1,089Revenue, FY2026, twelve months to 2026-03-31$1.09bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-05-14, accession 0001295947-26-000016.Report this figure
Gross margin%57.1%Gross margin, FY2022, twelve months to 2022-03-31. gross profit / revenueGross profit: $620.6m. XBRL concept us-gaap:GrossProfit. 10-K filed 2024-05-15, accession 0001295947-24-000017.Revenue: $1.09bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-05-15, accession 0001295947-24-000017.Report this figure55.4%Gross margin, FY2023, twelve months to 2023-03-31. gross profit / revenueGross profit: $625.3m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-05-09, accession 0001295947-25-000017.Revenue: $1.13bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-05-09, accession 0001295947-25-000017.Report this figure55.5%Gross margin, FY2024, twelve months to 2024-03-31. gross profit / revenueGross profit: $624.4m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-05-14, accession 0001295947-26-000016.Revenue: $1.13bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-05-14, accession 0001295947-26-000016.Report this figure55.8%Gross margin, FY2025, twelve months to 2025-03-31. gross profit / revenueGross profit: $634.5m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-05-14, accession 0001295947-26-000016.Revenue: $1.14bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-05-14, accession 0001295947-26-000016.Report this figure54.7%Gross margin, FY2026, twelve months to 2026-03-31. gross profit / revenueGross profit: $595.6m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-05-14, accession 0001295947-26-000016.Revenue: $1.09bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-05-14, accession 0001295947-26-000016.Report this figure
Operating margin%30.4%Operating margin, FY2022, twelve months to 2022-03-31. operating income / revenueOperating income: $329.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-05-15, accession 0001295947-24-000017.Revenue: $1.09bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-05-15, accession 0001295947-24-000017.Report this figure(2.0%)Operating margin, FY2023, twelve months to 2023-03-31. operating income / revenueOperating income: −$22.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-05-09, accession 0001295947-25-000017.Revenue: $1.13bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-05-09, accession 0001295947-25-000017.Report this figure30.4%Operating margin, FY2024, twelve months to 2024-03-31. operating income / revenueOperating income: $342.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-05-14, accession 0001295947-26-000016.Revenue: $1.13bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-05-14, accession 0001295947-26-000016.Report this figure29.6%Operating margin, FY2025, twelve months to 2025-03-31. operating income / revenueOperating income: $336.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-05-14, accession 0001295947-26-000016.Revenue: $1.14bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-05-14, accession 0001295947-26-000016.Report this figure28.4%Operating margin, FY2026, twelve months to 2026-03-31. operating income / revenueOperating income: $309.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-05-14, accession 0001295947-26-000016.Revenue: $1.09bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-05-14, accession 0001295947-26-000016.Report this figure
Net margin%18.9%Net margin, FY2022, twelve months to 2022-03-31. net income / revenueNet income: $205.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-05-15, accession 0001295947-24-000017.Revenue: $1.09bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-05-15, accession 0001295947-24-000017.Report this figure(7.3%)Net margin, FY2023, twelve months to 2023-03-31. net income / revenueNet income: −$82.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-05-09, accession 0001295947-25-000017.Revenue: $1.13bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-05-09, accession 0001295947-25-000017.Report this figure18.6%Net margin, FY2024, twelve months to 2024-03-31. net income / revenueNet income: $209.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-05-14, accession 0001295947-26-000016.Revenue: $1.13bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-05-14, accession 0001295947-26-000016.Report this figure18.9%Net margin, FY2025, twelve months to 2025-03-31. net income / revenueNet income: $214.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-05-14, accession 0001295947-26-000016.Revenue: $1.14bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-05-14, accession 0001295947-26-000016.Report this figure17.5%Net margin, FY2026, twelve months to 2026-03-31. net income / revenueNet income: $190.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-05-14, accession 0001295947-26-000016.Revenue: $1.09bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-05-14, accession 0001295947-26-000016.Report this figure
Diluted EPS$ per share4.04Diluted EPS, FY2022, twelve months to 2022-03-31$4.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-05-15, accession 0001295947-24-000017.Report this figure(1.65)Diluted EPS, FY2023, twelve months to 2023-03-31−$1.65 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-05-09, accession 0001295947-25-000017.Report this figure4.17Diluted EPS, FY2024, twelve months to 2024-03-31$4.17 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-05-14, accession 0001295947-26-000016.Report this figure4.29Diluted EPS, FY2025, twelve months to 2025-03-31$4.29 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-05-14, accession 0001295947-26-000016.Report this figure3.91Diluted EPS, FY2026, twelve months to 2026-03-31$3.91 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-05-14, accession 0001295947-26-000016.Report this figure
Free cash flow$m250Free cash flow, FY2022, twelve months to 2022-03-31. operating cash flow − capital expenditureOperating cash flow: $259.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-05-15, accession 0001295947-24-000017.Capital expenditure: $9.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-05-15, accession 0001295947-24-000017.Report this figure222Free cash flow, FY2023, twelve months to 2023-03-31. operating cash flow − capital expenditureOperating cash flow: $229.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-05-09, accession 0001295947-25-000017.Capital expenditure: $7.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-05-09, accession 0001295947-25-000017.Report this figure239Free cash flow, FY2024, twelve months to 2024-03-31. operating cash flow − capital expenditureOperating cash flow: $248.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-05-14, accession 0001295947-26-000016.Capital expenditure: $9.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-05-14, accession 0001295947-26-000016.Report this figure243Free cash flow, FY2025, twelve months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: $251.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-05-14, accession 0001295947-26-000016.Capital expenditure: $8.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-05-14, accession 0001295947-26-000016.Report this figure246Free cash flow, FY2026, twelve months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: $257.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-05-14, accession 0001295947-26-000016.Capital expenditure: $11.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-05-14, accession 0001295947-26-000016.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Prestige Consumer Healthcare Inc.
FundQuarter endedReported valueSharesPut or callChange on the quarter before
BlackRock, Inc.2026-06-30$370.2m7,831,333Added+442,843
ARIEL INVESTMENTS, LLC2026-06-30$230.1m4,868,711Added+594,385
VANGUARD PORTFOLIO MANAGEMENT LLC2026-06-30$133.6m2,825,340Added+21,512
DIMENSIONAL FUND ADVISORS LP2026-06-30$125.8m2,661,291Reduced−11,486
FULLER & THALER ASSET MANAGEMENT, INC.2026-06-30$110.2m2,331,821New+2,331,821
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$101.0m2,136,944Added+43,951
STATE STREET CORP2026-06-30$100.0m2,116,513Added+145,532
BRANDES INVESTMENT PARTNERS, LP2026-06-30$97.0m2,051,060Added+1,196,941
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC2026-06-30$88.5m1,872,023Reduced−330,583
GEODE CAPITAL MANAGEMENT, LLC2026-06-30$74.3m1,571,742Added+111,707

Recent filings

All 985 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Prestige Consumer Healthcare Inc., recent filings
FiledFormWhat it isAccession number
2026-08-1416:03 ET8-K5.02 Departure or appointment of officers or directors0001295947-26-000049
2026-08-0606:15 ET10-QQuarterly reportPeriod 2026-06-300001295947-26-000042
2026-08-0606:04 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001295947-26-000040
2026-07-1516:03 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001104659-26-083872
2026-07-0916:43 ET8-K/A9.01 Financial statements and exhibits0001295947-26-000032
2026-07-0608:05 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001295947-26-000029
2026-06-3006:01 ET8-K/A9.01 Financial statements and exhibits0001295947-26-000025
2026-06-2906:06 ETDEF 14AProxy statementPeriod 2026-06-290001295947-26-000021
2026-06-1606:15 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-26-074259
2026-05-1416:32 ET10-KAnnual reportPeriod 2026-03-310001295947-26-000016

Latest annual report

Form 10-K for the fiscal year ended Mar 31, 2026Filed May 14, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q2 FY2027, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by [object Promise].Forecast this quarter

About the filer

CIK
1295947
Tickers
PBH
Exchange
NYSE
SIC code
2834 Pharmaceutical Preparations
Sector
Healthcare
Fiscal year ends
Mar 31
Incorporated in
not reported
Filer category
Large accelerated filer
Former names
Prestige Brands Holdings, Inc. (to 2018-08-10)

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:36 ET. Listed shows no prices and gives no investment advice.